Are there long-term effects of extracorporeal shockwave lithotripsy in paediatric patients?

Ahmed R El-Nahas1, Bassam A Awad, Ahmed M El-Assmy

  • 1Urology Department, Urology and Nephrology Centre, Mansoura University, Mansoura, Egypt. ar_el_nahas@yahoo.com

BJU International
|August 29, 2012
PubMed

Insights

Extracorporeal shockwave lithotripsy (SWL) is safe for children with kidney stones, showing no long-term effects on renal growth, blood pressure, or blood sugar. This study confirms SWL

Area of Science:

  • Pediatric Urology
  • Nephrology
  • Surgical Innovation

Background:

  • Extracorporeal shockwave lithotripsy (SWL) is a common treatment for pediatric renal stones.
  • Short-term safety and efficacy of SWL in children are established.
  • Long-term outcomes regarding renal growth and metabolic health require further investigation.

Purpose of the Study:

  • To evaluate the long-term effects of extracorporeal shockwave lithotripsy (SWL) on renal growth and metabolic parameters in pediatric patients.
  • To assess the safety of SWL monotherapy for treating renal stones in children over an extended follow-up period.

Main Methods:

  • Retrospective analysis of 70 pediatric patients treated with SWL monotherapy between 1990 and 2009.
  • Inclusion criteria required a minimum follow-up of 2 years.
  • Long-term assessment included blood pressure, blood sugar, urinalysis, and renal ultrasonography for renal length and stone detection.

Main Results:

  • No patients developed hypertension or diabetes mellitus during a mean follow-up of 5.2 years.
  • Renal growth was unaffected in most patients; only one treated kidney showed reduced length, attributed to ureteral obstruction.
  • The study included 70 children (63% boys) with a mean age of 6.5 years at SWL, followed up to a mean age of 11.7 years.

Conclusions:

  • Extracorporeal shockwave lithotripsy (SWL) is a safe and effective treatment for pediatric renal stones.
  • Long-term follow-up demonstrates no adverse effects on renal growth, hypertension, or diabetes development.
  • SWL can be considered a reliable therapeutic option for pediatric kidney stone management.
Abstract